A detailed history of Hap Trading, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 35,000 shares of AXSM stock, worth $3.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,000
Holding current value
$3.42 Million
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$30.7 - $43.36 $121,664 - $171,835
-3,963 Reduced 25.5%
11,580 $437,000
Q3 2021

Nov 10, 2021

SELL
$19.91 - $68.26 $85,155 - $291,948
-4,277 Reduced 21.58%
15,543 $512,000
Q2 2021

Aug 11, 2021

BUY
$50.63 - $73.5 $312,640 - $453,862
6,175 Added 45.25%
19,820 $1.34 Million
Q1 2020

May 08, 2020

BUY
$41.2 - $101.31 $562,174 - $1.38 Million
13,645 New
13,645 $803,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.19B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.